US FDA finds new manufacturing lapses at Eli Lilly plant
Lilly said in a statement that tirzepatide, the active ingredient in Mounjaro and Zepbound, was not manufactured at the Branchburg plant
Lilly said in a statement that tirzepatide, the active ingredient in Mounjaro and Zepbound, was not manufactured at the Branchburg plant
Elrexfio will be sold in the United States at a list price of $7,556 and $13,051 for the 44 mg and the 76 mg vial, respectively, Pfizer said
Shares of Amneal Pharmaceuticals fell 13.1% to $2.7 in choppy after-market trading
The FDA's decision makes Litfulo the first to be allowed for the treatment of the condition in adolescents